Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study In People With Type 2 Diabetes

ClinicalTrials.gov ID: NCT00196989

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00196989. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 2:22 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study of Oral GW677954 as a Monotherapy for 12 Weeks Duration in Patients With Type 2 Diabetes Mellitus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This Phase 2 dose-ranging study will evaluate the efficacy, safety and tolerability of a range of doses of GW677954 compared with placebo over sixteen weeks of treatment in subjects with T2DM (Type 2 Diabetes Mellitus).

Study identification

NCT ID
NCT00196989
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
448 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2005 (Type not available)
Primary completion
Apr 2007 (Actual)
Completion
Apr 2007 (Actual)
Last update posted
Mar 23, 2017

2005 – 2007

United States locations

U.S. sites
69
U.S. states
26
U.S. cities
60
Facility City State ZIP Site status
GSK Investigational Site Birmingham Alabama 35205 —
GSK Investigational Site Northport Alabama 35476 —
GSK Investigational Site Chandler Arizona 85224 —
GSK Investigational Site Phoenix Arizona 85006 —
GSK Investigational Site Phoenix Arizona 85032 —
GSK Investigational Site Alhambra California 91801 —
GSK Investigational Site Artesia California 90701 —
GSK Investigational Site Huntington Beach California 92648 —
GSK Investigational Site Inglewood California 90301 —
GSK Investigational Site Irvine California 92618 —
GSK Investigational Site La Jolla California 92037 —
GSK Investigational Site Long Beach California 90806 —
GSK Investigational Site Los Angeles California 90057 —
GSK Investigational Site Los Angeles California 90095 —
GSK Investigational Site Northridge California 91325 —
GSK Investigational Site Norwalk California 90650 —
GSK Investigational Site Pasadena California 91105 —
GSK Investigational Site Sacramento California 95825 —
GSK Investigational Site San Diego California 92128 —
GSK Investigational Site San Diego California 92177 —
GSK Investigational Site Santa Monica California 90404 —
GSK Investigational Site Tustin California 92780 —
GSK Investigational Site Vista California 92084 —
GSK Investigational Site West Hills California 91307 —
GSK Investigational Site Denver Colorado 80220 —
GSK Investigational Site Norwich Connecticut 06360 —
GSK Investigational Site Hollywood Florida 33021 —
GSK Investigational Site Hollywood Florida 33023 —
GSK Investigational Site Largo Florida 33773 —
GSK Investigational Site Miami Florida 33156 —
GSK Investigational Site Saint Cloud Florida 34769 —
GSK Investigational Site Sarasota Florida 34239 —
GSK Investigational Site Atlanta Georgia 30342 —
GSK Investigational Site Duluth Georgia 30097 —
GSK Investigational Site Honolulu Hawaii 96813 —
GSK Investigational Site Springfield Illinois 62701 —
GSK Investigational Site Indianapolis Indiana 46260 —
GSK Investigational Site West Yarmouth Massachusetts 02673 —
GSK Investigational Site St Louis Missouri 63110 —
GSK Investigational Site St Louis Missouri 63141 —
GSK Investigational Site Henderson Nevada 89014 —
GSK Investigational Site Henderson Nevada 89015 —
GSK Investigational Site Las Vegas Nevada 89106 —
GSK Investigational Site Las Vegas Nevada 89119 —
GSK Investigational Site Las Vegas Nevada 89128 —
GSK Investigational Site Pahrump Nevada 89048 —
GSK Investigational Site Albuquerque New Mexico 87102 —
GSK Investigational Site Santa Fe New Mexico 87505 —
GSK Investigational Site New York New York 10024 —
GSK Investigational Site New York New York 10032 —
GSK Investigational Site Greensboro North Carolina 27401 —
GSK Investigational Site Cleveland Ohio 44195 —
GSK Investigational Site Franklin Ohio 45005 —
GSK Investigational Site Philadelphia Pennsylvania 19107 —
GSK Investigational Site East Providence Rhode Island 02914 —
GSK Investigational Site Greer South Carolina 29651 —
GSK Investigational Site Simpsonville South Carolina 29681 —
GSK Investigational Site Cite Tennessee 37604 —
GSK Investigational Site Kingsport Tennessee 37660 —
GSK Investigational Site Dallas Texas 75246 —
GSK Investigational Site San Antonio Texas 78229 —
GSK Investigational Site Tyler Texas 75708 —
GSK Investigational Site Salt Lake City Utah 84109 —
GSK Investigational Site West Jordan Utah 84084 —
GSK Investigational Site Virginia Beach Virginia 23451 —
GSK Investigational Site Edmonds Washington 98026 —
GSK Investigational Site Everett Washington 98208 —
GSK Investigational Site Monroe Washington 98272 —
GSK Investigational Site Wauwatosa Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 74 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00196989, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 23, 2017 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.